EMAIL THIS PAGE TO A FRIEND

Investigative ophthalmology & visual science

Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease.


PMID 26024097

Abstract

The contribution of lymphangiogenesis (LA) to allergy has received considerable attention and therapeutic inhibition of this process via targeting VEGF has been considered. Likewise, certain inflammatory settings affecting the ocular mucosa can trigger pathogenic LA in the naturally avascular cornea. Chronic inflammation in allergic eye disease (AED) impacts the conjunctiva and cornea, leading to sight threatening conditions. However, whether corneal LA is involved is completely unknown. We addressed this using a validated mouse model of AED. Allergic eye disease was induced by ovalbumin (OVA) immunization and chronic OVA exposure. Confocal microscopy of LYVE-1-stained cornea allowed evaluation of corneal LA, and qRT-PCR was used to evaluate expression of VEGF-C, -D, and -R3 in these mice. Administration of VEGF receptor (R) inhibitor was incorporated to inhibit corneal LA in AED. Immune responses were evaluated by in vitro OVA recall responses of T cells, and IgE levels in the serum. Confocal microscopy of LYVE-1-stained cornea revealed the distinct presence of corneal LA in AED, and corroborated by increased corneal expression of VEGF-C, -D, and -R3. Importantly, prevention of corneal LA in AED via VEGFR inhibition was associated with decreased T helper two responses and IgE production. Furthermore, VEGFR inhibition led a significant reduction in clinical signs of AED. Collectively, these data reveal that there is a distinct involvement of corneal LA in AED. Furthermore, VEGFR inhibition prevents corneal LA and consequent immune responses in AED.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2101409
Anti-LYVE1 antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB4300606
Anti-LYVE1 antibody produced in rabbit, affinity isolated antibody
SAB1300253
Anti-XLKD1 (C-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1300632
Anti-XLKD1 (N-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1307078
ANTI-XLKD1(N-TERMINAL) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
PZ0193
Axitinib, ≥98% (HPLC)
C22H18N4OS
RAB0298
Human IL-4 ELISA Kit, for serum, plasma, cell culture supernatant and urine
SRP6172
IL-4 human, recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE)
SRP3093 IL-4 human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
I4269 Interleukin-4 human, IL-4, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
H7291 Interleukin-4 human, IL-4, potency:, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture
I2661 Interleukin-4 human, IL-4, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), animal component free
RAB0299
Mouse IL-4 ELISA Kit, for serum, plasma and cell culture supernatant
RAB0300
Mouse IL-4 ELISA Kit, for cell and tissue lysates
RAB0301
Rat IL-4 ELISA Kit, for serum, plasma and cell culture supernatant
RAB0302
Rat IL-4 ELISA Kit, for cell and tissue lysates